A drug known as SP-2577 could help enable the body's own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Jul 13, 2020
0
18
A type of drug known as a PARP inhibitor, already used to treat breast and ovarian cancer, may be useful in treating children with high-risk neuroblastoma—a common childhood tumor with a low survival rate.
Jun 25, 2020
0
6
A US court has upheld a verdict that talcum powder sold by Johnson & Johnson caused ovarian cancer and ordered the pharmaceutical giant to pay $2.1 billion in damages.
Jun 24, 2020
0
5
(HealthDay)—Statin drugs, used for decades to treat high cholesterol, may also reduce deaths for women with ovarian cancer, a new study suggests.
Jun 22, 2020
0
112
Imagine a line of dominoes. When one is lightly tapped and falls, the rest tumble.
Jun 19, 2020
0
2
Scientists have found that a specific type of ovarian cancer could possibly benefit from existing platinum-based chemotherapy and new DNA repairing treatments, following better testing.
Jun 8, 2020
0
7
(HealthDay)—Screening for breast and ovarian cancer genes might be added to the list of medical tests that can be safely and effectively done from home, new research suggests.
Jun 3, 2020
0
4
Around 1500 Australian women will be diagnosed with ovarian cancer this year, and one woman will die every eight hours from this disease.
May 26, 2020
0
142
(HealthDay)—Lawsuits claiming that talc-based Johnson's Baby Powder has caused cancer have led to a plunge in sales in the United States and Canada, so Johnson & Johnson said Tuesday it is ending sales of the product in ...
May 21, 2020
0
0
The rogue cellular engine that drives a majority of ovarian cancers remains frustratingly difficult to disable. A new study comparing cancerous tissue with normal fallopian tube samples advances important insights about this ...
May 19, 2020
0
23
